Canaan (CAN) Research & Development (2018 - 2026)

Canaan has disclosed Research & Development across 9 years of filings, most recently posting -$15.4 million for Q1 2026.

• In Q1 2026, Research & Development rose 18.77% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$59.6 million (up 8.22% YoY), while the FY2025 annual figure was $63.1 million, up 2.97% from the prior year.
• Research & Development declined to -$15.4 million in Q1 2026, from -$11.5 million in the prior quarter.
• Over the last five years, Research & Development for CAN reached as high as -$10.8 million in Q4 2023 and fell as low as -$33.4 million in Q4 2022.
• The 5-year median for Research & Development is -$16.3 million (2025), against an average of -$16.9 million.
• Annual changes were most pronounced in 2022 — Research & Development plunged 89.81% — and 2023, when it jumped 67.7%.
• A 5-year view of Research & Development shows it stood at -$33.4 million in 2022, then jumped by 67.7% to -$10.8 million in 2023, then tumbled by 53.76% to -$16.6 million in 2024, then soared by 30.87% to -$11.5 million in 2025, then plunged by 34.34% to -$15.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$15.4 million, -$11.5 million, and -$16.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.